Eli Lilly Shares Surge Following Recent Acquisition
Eli Lilly strengthens its presence in cancer treatment with the completion of its $1.4 billion acquisition of Point Biopharma, expanding ...
- Latest
- Trending
Eli Lilly strengthens its presence in cancer treatment with the completion of its $1.4 billion acquisition of Point Biopharma, expanding ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.